| Literature DB >> 9786248 |
P Piccardo1, S R Dlouhy, P M Lievens, K Young, T D Bird, D Nochlin, D W Dickson, H V Vinters, T R Zimmerman, I R Mackenzie, S J Kish, L C Ang, C De Carli, M Pocchiari, P Brown, C J Gibbs, D C Gajdusek, O Bugiani, J Ironside, F Tagliavini, B Ghetti.
Abstract
Gerstmann-Sträussler-Scheinker disease (GSS), a cerebello-pyramidal syndrome associated with dementia and caused by mutations in the prion protein gene (PRNP), is phenotypically heterogeneous. The molecular mechanisms responsible for such heterogeneity are unknown. Since we hypothesize that prion protein (PrP) heterogeneity may be associated with clinico-pathologic heterogeneity, the aim of this study was to analyze PrP in several GSS variants. Among the pathologic phenotypes of GSS, we recognize those without and with marked spongiform degeneration. In the latter (i.e. a subset of GSS P102L patients) we observed 3 major proteinase-K resistant PrP (PrPres) isoforms of ca. 21-30 kDa, similar to those seen in Creutzfeldt-Jakob disease. In contrast, the 21-30 kDa isoforms were not prominent in GSS variants without spongiform changes, including GSS A117V, GSS D202N, GSS Q212P, GSS Q217R, and 2 cases of GSS P102L. This suggests that spongiform changes in GSS are related to the presence of high levels of these distinct 21-30 kDa isoforms. Variable amounts of smaller, distinct PrPres isoforms of ca. 7-15 kDa were seen in all GSS variants. This suggests that GSS is characterized by the presence PrP isoforms that can be partially cleaved to low molecular weight PrPres peptides.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9786248 DOI： 10.1097/00005072-199810000-00010
Source DB: PubMed Journal: J Neuropathol Exp Neurol ISSN： 0022-3069 Impact factor: 3.685